Efficacy and Safety of CPX-351 Versus 7+3 in a Phase 3...

Biology of Blood and Marrow Transplantation 2020 / 03 Vol. 26; Iss. 3

Efficacy and Safety of CPX-351 Versus 7+3 in a Phase 3 Exploratory Analysis in Patients with High-Risk/Secondary Acute Myeloid Leukemia (sAML) with Prior Hypomethylating Agent (HMA) Exposure Who Achieved Remission

Lin, Tara, Ryan, Daniel H., Ritchie, Ellen K., Strickland, Stephen A., Hogge, Donna E., Solomon, Scott R., Kolitz, Jonathan E., Schiller, Gary J., Wieduwilt, Matthew J., Ryan, Robert J., Faderl, Stefa
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2019.12.605
Date:
March, 2020
File:
PDF, 57 KB
2020
Conversion to is in progress
Conversion to is failed